Amicus Therapeutics (FOLD) Stock Forecast
AI forecast: FOLD
There is no current AI forecast for this stock.
The AI publishes a target price for the next trading day, the end of the week and the end of the month. The change is measured from the latest price. These are statistical estimates, not investment advice.
Premium shows the AI's price targets for 1 day, 1 week and 1 month for this and every other stock.
Unlock PremiumAbout This Company
Amicus Therapeutics, Inc. is a global biotechnology company focused on discovering, developing, and delivering new, high-quality medicines for people with rare metabolic diseases. The company is committed to advancing and expanding its portfolio of advanced, first-in-class, or best-in-class therapies for rare metabolic disorders.